Cyclooxygenase-2 expression and recurrence of colorectal adenomas: Effect of aspirin chemoprevention

Current Colorectal Cancer Reports

Volumn 7, Issue 1, 2011, Pages 5-7

  Kraus, Sarah ^a   Arber, Nadir ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLIN D1; CYCLOOXYGENASE 2; K RAS PROTEIN; PLACEBO; PROTEIN P54;

ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLONOSCOPY; COLORECTAL ADENOMA; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DYSPLASIA; GENE OVEREXPRESSION; HUMAN; LOW DRUG DOSE; PROTEIN EXPRESSION; RECURRENCE RISK; TUMOR RECURRENCE;

EID: 79952694317     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-010-0081-y     Document Type: Article

References (10)

1. Tomozawa S, Tsuno NH, Sunami E, et al.: Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 2000, 83:324-328. (Pubitemid 30453571)
2. Zhang H, Sun XF: Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol 2002, 97:1037-1041. (Pubitemid 34408266)
3. Soumaoro LT, Uetake H, Higuchi T, et al.: Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004, 10:8465-8471. (Pubitemid 40053411)
4. Axelsson H, Lönnroth C, Andersson M, Lundholm K: Mechanisms behind COX-1 and COX-2 inhibition of tumor growth in vivo. Int J Oncol 2010, 37:1143-1152.
5. Sheehan KM, O'Connell F, O'Grady A, et al.: The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas. Eur J Gastroenterol Hepatol 2004, 16:619-625. (Pubitemid 38703872)
6. Benamouzig R,Yoon H, Little J, et al.: APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings. Eur J Cancer Prev 2001, 10:327-335. (Pubitemid 32735349)
7. Ishiguro K, Yoshida T, Yagishita H, et al.: Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006, 55:695-702.
8. Chan AT, Ogino S, Fuchs CS: Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007, 356:2131-2142. (Pubitemid 47010839)
9. Patrono C: The PGH-synthase system and isozyme-selective inhibition. J Cardiovasc Pharmacol 2006, 47(Suppl 1):S1-S6.
10. Chiang N, Bermudez EA, Ridker PM, et al.: Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci U S A 2004, 101:15178-15183. (Pubitemid 39391738)